ABD’de yetişkinlerde bağışıklık arttırmaya yönelik rehber (İng)



Recommended Adult Immunization Schedule for 2013

Highlights of the updated recommendations and a link to the CDC’s vaccine resources

The U.S. Advisory Committee on Immunization Practices has issued updated guidelines for adult immunization. Highlights include the following:

  • 13-valent pneumococcal conjugate vaccine (PCV13) is recommended for adults (age, 19) with immunocompromising conditions (in addition to the pneumococcal polysaccharide vaccine, or PPSV23).
  • PPSV23 should be administered to elders (age, 65) and readministered to those who received one or two doses before age 65 if at least 5 years have passed.
  • Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination is recommended for elders (age, 65) and for pregnant women (at 27–36 weeks’ gestation) to help protect newborns.
  • Live attenuated influenza vaccine (LAIV) for the 2013–2014 season likely will be available only as a quadrivalent vaccine (including 2 influenza A strains, H3N2 and H1N1, and 2 influenza B strains), which is expected to improve coverage beyond that of the previous trivalent vaccine.
  • Patients who experience only hives from egg exposure should receive inactivated influenza vaccine (IIV) rather than LAIV. IIV might be available in both the trivalent and quadrivalent forms for 2013–2014.
  • Bivalent human papillomavirus vaccine (HPV2) or quadrivalent vaccine (HPV4) are recommended for girls and women, and HPV4 is recommended for boys and men.

Comment: Levels of vaccination adherence remain low, and a strong recommendation from providers is associated with better adherence. The CDC website is an excellent resource for all vaccine-related issues